Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study

¹Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan;
²Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan;
³Department of Surgery, Tohoku University Graduate School of Medicine, Miyagi, Japan;
⁴Department of Surgery I, Yamagata University Graduate School of Medical Science, Yamagata, Japan;
⁵Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan;
⁶Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan;
⁷Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, Tokyo, Japan;
⁸Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East, Chiba, Japan;
⁹Department of Hepatobiliary-Pancreatic Surgery, Tochigi Cancer Center, Tochigi, Japan;
¹⁰Department of Gastroenterological Oncology, Hyogo Cancer Center, Hyogo, Japan;
¹¹Department of Clinical Oncology, Kagawa University, Kagawa, Japan;
¹²Department of Gastroenterological, Breast, and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan;
¹³Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan;
¹⁴Department of Hepatobiliary-Pancreatic Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan;
¹⁵Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan;
¹⁶Department of Gastroenterology, Aichi Cancer Center Hospital, Aichi, Japan;
¹⁷Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan

Correspondence to: Akiko Todaka, Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan. Tel: +81 559895222, Fax: +81 559895551, e-mail: a.todaka{at}scchr.jp

View Full Text